Brookpharm Limited 31/05/2025 iXBRL

Company registration number: 04751759

Brookpharm Limited

Unaudited filleted financial statements

31 May 2025

Brookpharm Limited

Contents

Statement of financial position

Statement of changes in equity

Notes to the financial statements

Brookpharm Limited

Statement of financial position

31 May 2025

		2025		2024
	Note	£	£	£	£

Fixed assets
Intangible assets	6	300,000		330,000
Tangible assets	7	1,384		1,628
		_______		_______
			301,384		331,628

Current assets
Stocks		32,581		35,329
Debtors	8	3,076,173		1,625,123
Cash at bank and in hand		92,961		1,396,504
		_______		_______
		3,201,715		3,056,956
Creditors: amounts falling due
within one year	9	( 239,647)		( 268,800)
		_______		_______
Net current assets			2,962,068		2,788,156
			_______		_______
Total assets less current liabilities			3,263,452		3,119,784

			_______		_______
Net assets			3,263,452		3,119,784
			_______		_______

Capital and reserves
Called up share capital			100		100
Profit and loss account			3,263,352		3,119,684
			_______		_______
Shareholders funds			3,263,452		3,119,784
			_______		_______

For the year ending 31 May 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;

- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.

These financial statements were approved by the board of directors and authorised for issue on 28 May 2026 , and are signed on behalf of the board by:

Mr Jaent Kumar Phakkey

Director

Company registration number: 04751759

Brookpharm Limited

Statement of changes in equity

Year ended 31 May 2025

	Called up share capital	Profit and loss account	Total
	£	£	£


At 1 June 2023	100	2,969,189	2,969,289

Profit for the year		151,495	151,495
	_______	_______	_______
Total comprehensive income for the year	-	151,495	151,495

Dividends paid and payable		( 1,000)	( 1,000)
	_______	_______	_______
Total investments by and distributions to owners	-	( 1,000)	( 1,000)

	_______	_______	_______
At 31 May 2024 and 1 June 2024	100	3,119,684	3,119,784

Profit for the year		144,668	144,668
	_______	_______	_______
Total comprehensive income for the year	-	144,668	144,668

Dividends paid and payable		( 1,000)	( 1,000)
	_______	_______	_______
Total investments by and distributions to owners	-	( 1,000)	( 1,000)

	_______	_______	_______
At 31 May 2025	100	3,263,352	3,263,452
	_______	_______	_______

Brookpharm Limited

Notes to the financial statements

Year ended 31 May 2025

1. General information

The company is a private company limited by shares, registered in United Kingdom. The address of the registered office is 109 Chinbrook Road, Grove Park, Lewisham, SE12 9QL.

2. Statement of compliance

These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Turnover

Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Taxation

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

Goodwill

Goodwill arises on business acquisitions and represents the excess of the cost of the acquisition over the company's interest in the net amount of the identifiable assets, liabilities and contingent liabilities of the acquired business. Goodwill is measured at cost less accumulated amortisation and accumulated impairment losses. It is amortised on a straight line basis over its useful life. Where a reliable estimate of the useful life of goodwill or intangible assets cannot be made, the life is presumed not to exceed ten years.

Amortisation

Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:

If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.

Tangible assets

tangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in capital and reserves, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess shall be recognised in profit or loss.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:


Fittings fixtures and equipment	-	15 %	reducing balance
Motor vehicles	-	20 %	reducing balance

If there is an indication that there has been a significant change in depreciation rate, useful life or residual value of tangible assets, the depreciation is revised prospectively to reflect the new estimates.

Impairment

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. When it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.

Stocks

Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stocks to their present location and condition.

Financial instruments

The company holds only basic financial instruments such as cash, debtors and creditors, for which carrying amount is equivalent to fair value.

Defined contribution plans

Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised in finance costs in profit or loss in the period in which it arises.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business. Trade debtors are recognised initially at the transaction price. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

4. Employee numbers

The average number of persons employed by the company during the year amounted to 4 (2024: 4 ).

5. Directors remuneration

The directors aggregate remuneration in respect of qualifying services was:

	2025	2024
	£	£
Remuneration	18,000	18,000
	_______	_______

6. Intangible assets

	Goodwill	Total
	£	£
Cost
At 1 June 2024 and 31 May 2025	600,000	600,000
	_______	_______
Amortisation
At 1 June 2024	270,000	270,000
Charge for the year	30,000	30,000
	_______	_______
At 31 May 2025	300,000	300,000
	_______	_______
Carrying amount
At 31 May 2025	300,000	300,000
	_______	_______
At 31 May 2024	330,000	330,000
	_______	_______

7. Tangible assets

	Fixtures, fittings and equipment	Motor vehicles	Total
	£	£	£
Cost
At 1 June 2024 and 31 May 2025	7,701	-	7,701
	_______	_______	_______
Depreciation
At 1 June 2024	6,074	( 1)	6,073
Charge for the year	244	-	244
	_______	_______	_______
At 31 May 2025	6,318	( 1)	6,317
	_______	_______	_______
Carrying amount
At 31 May 2025	1,383	1	1,384
	_______	_______	_______
At 31 May 2024	1,627	1	1,628
	_______	_______	_______

8. Debtors

	2025	2024
	£	£
Trade debtors	74,121	61,881
Other debtors	3,002,052	1,563,242
	_______	_______
	3,076,173	1,625,123
	_______	_______

9. Creditors: amounts falling due within one year

	2025	2024
	£	£
Trade creditors	130,750	104,250
Corporation tax	58,303	129,139
Social security and other taxes	2,073	238
Other creditors	48,521	35,173
	_______	_______
	239,647	268,800
	_______	_______

10. Directors advances, credits and guarantees

	During the year the directors entered into the following advances and credits with the company:

2025
		Balance brought forward	Advances /(credits) to the directors	Balance o/standing
		£	£	£
	Mr Jaent Kumar Phakkey	( 8,756)	( 9,500)	( 18,256)
	Mrs. Maya Phakkey	( 8,756)	( 9,500)	( 18,256)
		_______	_______	_______
		( 17,512)	( 19,000)	( 36,512)
		_______	_______	_______

2024
		Balance brought forward	Advances /(credits) to the directors	Balance o/standing
		£	£	£
	Mr Jaent Kumar Phakkey	( 19,159)	10,403	( 8,756)
	Mrs. Maya Phakkey	( 19,159)	10,403	( 8,756)
		_______	_______	_______
		( 38,318)	20,806	( 17,512)
		_______	_______	_______

The loan is interest free and repayable on demand.